文献速递哮喘

哮喘多基因风险评分的表观基因组分区揭示不同遗传驱动疾病通路

Epigenomic partitioning of a polygenic risk score for asthma reveals distinct genetically driven disease pathways.
PubMed 文献 · Eur Respir J · 2024-08-29

利用19种疾病相关细胞类型的全基因组染色质数据对评分进行表观基因组分区,识别出五个变异簇,可能代表不同的遗传驱动疾病通路。

要点

  • 多基因风险评分可预测哮喘及相关结局,儿童期起病哮喘预测力更强。
  • 表观基因组分区将评分变异分为五个调控变异簇,关联不同细胞与通路。
  • 研究提示多基因风险评分可用于个性化风险分层与治疗策略。

核心结论

  • 多基因风险评分与荷兰前瞻性队列中的哮喘及相关特征相关,对儿童期起病哮喘的预测力显著高于成人期起病哮喘。
  • 评分变异可经表观基因组分区为具有不同病理生理关联模式和效应估计的调控变异簇,可能代表不同的遗传驱动疾病通路。

研究设计与样本

  • 结局包括哮喘、儿童期起病哮喘、成人期起病哮喘、嗜酸性粒细胞性哮喘和哮喘急性发作。
  • 使用19种疾病相关细胞类型的全基因组染色质分析数据进行表观基因组多基因风险评分分区。

主要发现

  • 多基因风险评分可预测哮喘及相关结局,对儿童期起病哮喘关联最强(每多基因风险评分标准差比值比2.55,曲线下面积0.760)。
  • 多基因风险评分可将个体分为高风险和低风险组。
  • 表观基因组分区识别出五个变异簇,位于推定基因调控区,与特定哮喘相关细胞、基因和生物学通路相关。

临床怎么用

  • 多基因风险评分可用于哮喘风险预测,尤其对儿童期起病哮喘预测力较强,有助于个性化风险分层。
  • 表观基因组分区揭示的调控变异簇可能为个性化风险缓解和治疗策略提供依据。

局限性

  • 研究基于荷兰前瞻性队列,结果外推至其他人群需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Individual differences in susceptibility to developing asthma, a heterogeneous chronic inflammatory lung disease, are poorly understood. Whether genetics can predict asthma risk and how genetic variants modulate the complex pathophysiology of asthma are still debated. AIM: To build polygenic risk scores for asthma risk prediction and epigenomically link predictive genetic variants to pathophysiological mechanisms. METHODS: Restricted polygenic risk scores were constructed using single nucleotide variants derived from genome-wide association studies and validated using data generated in the Rotterdam Study, a Dutch prospective cohort of 14 926 individuals. Outcomes used were asthma, childhood-onset asthma, adulthood-onset asthma, eosinophilic asthma and asthma exacerbations. Genome-wide chromatin analysis data from 19 disease-relevant cell types were used for epigenomic polygenic risk score partitioning. RESULTS: The polygenic risk scores obtained predicted asthma and related outcomes, with the strongest associations observed for childhood-onset asthma (2.55 odds ratios per polygenic risk score standard deviation, area under the curve of 0.760). Polygenic risk scores allowed for the classification of individuals into high-risk and low-risk groups. Polygenic risk score partitioning using epigenomic profiles identified five clusters of variants within putative gene regulatory regions linked to specific asthma-relevant cells, genes and biological pathways. CONCLUSIONS: Polygenic risk scores were associated with asthma(-related traits) in a Dutch prospective cohort, with substantially higher predictive power observed for childhood-onset than adult-onset asthma. Importantly, polygenic risk score variants could be epigenomically partitioned into clusters of regulatory variants with different pathophysiological association patterns and effect estimates, which likely represent distinct genetically driven disease pathways. Our findings have potential implications for personalised risk mitigation and treatment strategies.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Stikker B, Trap L, Sedaghati-Khayat B, et al. Epigenomic partitioning of a polygenic risk score for asthma reveals distinct genetically driven disease pathways. Eur Respir J. 2024. PMID: 38901884. doi:10.1183/13993003.02059-2023

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。